[1] |
ZHENG Wentian, GONG Hui, ZHANG Xinyue, HAO Jiayi, WANG Yajie, JIANG Yingying.
Effects of SEC14L1P1 on proliferation and migration of oral squamous cell carcinoma cells
[J]. China Oncology, 2025, 35(3): 309-319.
|
[2] |
LAN Yu, WANG Fenghua.
Comparison and review of updated guidelines for advanced gastric cancer diagnosis and treatment in 2024: CSCO, NCCN and ESMO
[J]. China Oncology, 2025, 35(2): 219-227.
|
[3] |
CAO Fei, YU Wenhao, TANG Xiaonan, MA Zidong, CHANG Tingmin, GONG Yabin, LIAO Mingjuan, KANG Xiaohong.
Mechanism of LINC01410 promoting proliferation and migration in esophageal squamous cell carcinoma
[J]. China Oncology, 2024, 34(8): 753-762.
|
[4] |
LIU Shuai, ZHANG Kai, ZHANG Xiaoqing, LUAN Wei.
An exploratory study on the perioperative treatment of locally advanced gastric cancer with combination of penpulimab, anlotinib and chemotherapy
[J]. China Oncology, 2024, 34(7): 659-668.
|
[5] |
SUN Rongqi, SONG Ning, ZHENG Wentian, ZHANG Xinyue, LI Minmin, GONG Hui, JIANG Yingying.
Effect of long noncoding RNA FLJ30679 on proliferation and migration of oral squamous cell carcinoma cells
[J]. China Oncology, 2024, 34(5): 439-450.
|
[6] |
WANG Fei, LIU Pei, HU Nan.
Effect of bevacizumab assisted PD-1 inhibitor on serum miR-20a-5p and miR-515-3p in the treatment of gastric cancer
[J]. China Oncology, 2024, 34(5): 493-500.
|
[7] |
Professional Committee on Gastric Cancer of Shanghai Anticancer Association , Professional Committee on Gastrointestinal Cancer of China Association for Promotion of Health Science and Technology .
Chinese expert consensus on clinical practice of locally advanced gastric cancer invading adjacent organs (2024 edition)
[J]. China Oncology, 2024, 34(5): 517-526.
|
[8] |
XU Yonghu, XU Dazhi.
Progress and prospects of gastric cancer treatment in the 21st century
[J]. China Oncology, 2024, 34(3): 239-249.
|
[9] |
WANG Xuefei, ZHOU Peng, TANG Zhaoqing.
New progress and development trend of surgical treatment for gastric cancer
[J]. China Oncology, 2024, 34(3): 250-258.
|
[10] |
XUE Chi, GAO Peng, ZHU Zhi, WANG Zhenning.
Application and challenge of immunotherapy in perioperative therapy of gastric cancer
[J]. China Oncology, 2024, 34(3): 259-267.
|
[11] |
SHEN Jie, WANG Jiangli, WANG Zezhou, MO Miao, ZHOU Changming, YUAN Jing, XU Dazhi, ZHENG Ying.
Survival analysis of 6 737 surgically resected gastric cancer cases in China from a large single institution hospital-based cancer registry database
[J]. China Oncology, 2024, 34(3): 268-277.
|
[12] |
LI Jing, ZHENG Lei, GAO Yu.
Analysis of effects of trastuzumab assisted modified DOF fortnightly regimen on serum tumor markers and survival rate in patients with cisplatin-resistant gastric cancer
[J]. China Oncology, 2024, 34(3): 286-292.
|
[13] |
FENG Huizhi, LIU Jingmei, BU Xiaoqian.
A retrospective study of pembrolizumab combined with XELOX regimen in the treatment of advanced gastric cancer
[J]. China Oncology, 2024, 34(11): 1028-1035.
|
[14] |
XU Ziqi, HU Ruizhi, LI Junjian, WANG Hongxia, SANG Youzhou.
Exploring the role of methylation-driven gene IFFO1 in pancreatic adenocarcinoma diagnosis, prognosis and cellular functions
[J]. China Oncology, 2024, 34(11): 998-1010.
|
[15] |
LIU Xuerou, YANG Yumei, ZHAO Qian, RONG Xiangyu, LIU Wei, ZHENG Ruijie, PANG Jinlong, LI Xian, LI Shanshan.
Research progress on the role of glutamine metabolism-related proteins in tumor metastasis
[J]. China Oncology, 2024, 34(1): 97-103.
|